Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 18 April 2019

 
 
 
   

News

 

Health industries welcome unprecedented progress leading to an adoption of Horizon Europe,...
17 April 2019

The text agreed allows our sectors to remain ambitious about a healthier future for European citizens, based on medical... Read more

Redressing Europe’s innovation balance
17 April 2019

As the waiver will hit innovation in Europe, the research-based industry stands ready to work with policy makers across... Read more

 
 
 
   

Videos

 
EFPIA Manifesto: Building a healthier future for Europe
We have a vision for a healthier world. We can see a brighter tomorrow for all patients. #WeWontRest until we get there.Read more

European Excellence: Making the EU a world leader in medical R&D
We want Europe to be the world leader in medical R&D. The pharmaceutical industry created a trade surplus of €79.7... Read more

 
 
 
   

Events

 

EFPIA 2019 Annual Conference
27 June 2019 (Radisson Blu Royal Hotel, Brussels, Belgium)

Making connections can advance patient care and support the European economy at a time of significant change and challenge... Read more

EFPIA Oncology Data Summit: Unleashing the potential of data to improve cancer care
18 June 2019 (Brussels)

The Summit will bring together cancer and data players from around Europe to actively participate in identifying the... Read more

ICHOM conference 2019
02 May 2019 (Rotterdam, The Netherlands)

The world-leading event for providers, life sciences and industry on value-based healthcare Read more

IMI Stakeholder Forum 2019
12 June 2019 (Royal Museums of Fine Arts of Belgium)

Brain health and disease in the digital era - 2020 and beyond Read more

 
 
 
   

What we are reading

 
Innovative Medicines Initiative launches Translational Safety Biomarker Pipeline Project
On 15 April 2019 (Eurek Alert)

The University of Zurich coordinates a worldwide research project that focuses on the development of new biomarkers.... Read more